A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay

Holly R Ramage1,2, G Renuka Kumar1,2, Erik Verschueren2,3

  • 1Gladstone Institutes, 1650 Owens Street, San Francisco, CA 94158, USA.

Molecular Cell
|January 24, 2015
PubMed

Insights

Hepatitis C virus (HCV) infection disrupts host cell functions by altering protein interactions, particularly involving mitochondrial proteins and the nonsense-mediated mRNA decay pathway. This study maps key interactions to reveal how HCV perturbs cellular mechanisms.

Area of Science:

  • Virology
  • Molecular Biology
  • Hepatology

Background:

  • Hepatitis C virus (HCV) is a major cause of liver disease.
  • Understanding virus-host interactions is crucial for developing antiviral strategies.

Purpose of the Study:

  • To comprehensively map host protein interactions for all ten HCV proteins.
  • To identify host factors and pathways disrupted by HCV infection.

Main Methods:

  • Affinity purification coupled with mass spectrometry to identify HCV-host protein-protein interactions.
  • RNA interference (RNAi) screening to assess the functional significance of host interactions.
  • A two-step scoring approach to establish high-confidence interaction networks.

Main Results:

  • A map of 139 high-confidence HCV-host protein-protein interactions was generated.
  • Mitochondrial proteins were identified as significantly involved in HCV infection.
  • HCV core protein interaction with WIBG disrupts the nonsense-mediated mRNA decay pathway, leading to transcript accumulation.

Conclusions:

  • This study provides a detailed map of HCV-host interactions.
  • HCV perturbs host cellular surveillance mechanisms, such as nonsense-mediated mRNA decay, to facilitate infection.
  • These findings offer insights into HCV pathogenesis and potential therapeutic targets.

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
12.2K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

3.7K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
9.4K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
63
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
98